Managing dry skin in patients with comorbidities or with advanced age : unmet needs and roles for products containing potential emollient-plus ingredients
In dry skin (DS), skin-barrier function is easily disturbed and moisturizing factors in the stratum corneum are reduced. Despite being a common condition, DS is often overlooked in patients with advanced age or comorbid diseases. In September 2022, specialists in dermatology and skin care met to discuss unmet needs and management of patients with DS with existing medical conditions or DS induced by ongoing pharmacological treatments. There was consensus about the need to improve the current understanding and management of DS in patients with comorbidities, including type 2 diabetes, chronic kidney disease, radiodermatitis, and photodamaged skin. Clinical guidance related to optimal treatment of DS in patients with advanced age or comorbid diseases is needed. Dexpanthenol-containing emollients have been shown to provide rapid relief from the symptoms and clinical signs of skin inflammation and are well-tolerated and effective in terms of moisturizing and soothing DS and maintaining skin-barrier function. Thus, dexpanthenol-containing emollients may play an important role in future management of DS. Further research is needed to elucidate the efficacy of dexpanthenol across the spectrum of DS, irrespective of comorbidity status or age.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:35 |
|---|---|
| Enthalten in: |
The Journal of dermatological treatment - 35(2024), 1 vom: 03. Apr., Seite 2326171 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Augustin, Matthias [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
19F5HK2737 |
|---|
| Anmerkungen: |
Date Completed 04.04.2024 Date Revised 04.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1080/09546634.2024.2326171 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370546385 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370546385 | ||
| 003 | DE-627 | ||
| 005 | 20240404235400.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240404s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/09546634.2024.2326171 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1364.xml |
| 035 | |a (DE-627)NLM370546385 | ||
| 035 | |a (NLM)38565198 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Augustin, Matthias |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Managing dry skin in patients with comorbidities or with advanced age |b unmet needs and roles for products containing potential emollient-plus ingredients |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.04.2024 | ||
| 500 | |a Date Revised 04.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a In dry skin (DS), skin-barrier function is easily disturbed and moisturizing factors in the stratum corneum are reduced. Despite being a common condition, DS is often overlooked in patients with advanced age or comorbid diseases. In September 2022, specialists in dermatology and skin care met to discuss unmet needs and management of patients with DS with existing medical conditions or DS induced by ongoing pharmacological treatments. There was consensus about the need to improve the current understanding and management of DS in patients with comorbidities, including type 2 diabetes, chronic kidney disease, radiodermatitis, and photodamaged skin. Clinical guidance related to optimal treatment of DS in patients with advanced age or comorbid diseases is needed. Dexpanthenol-containing emollients have been shown to provide rapid relief from the symptoms and clinical signs of skin inflammation and are well-tolerated and effective in terms of moisturizing and soothing DS and maintaining skin-barrier function. Thus, dexpanthenol-containing emollients may play an important role in future management of DS. Further research is needed to elucidate the efficacy of dexpanthenol across the spectrum of DS, irrespective of comorbidity status or age | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Dry skin | |
| 650 | 4 | |a comorbidities | |
| 650 | 4 | |a dermatitis | |
| 650 | 4 | |a dexpanthenol | |
| 650 | 4 | |a xerosis | |
| 650 | 7 | |a Emollients |2 NLM | |
| 650 | 7 | |a dexpanthenol |2 NLM | |
| 650 | 7 | |a 1O6C93RI7Z |2 NLM | |
| 650 | 7 | |a Pharmaceutical Vehicles |2 NLM | |
| 650 | 7 | |a Pantothenic Acid |2 NLM | |
| 650 | 7 | |a 19F5HK2737 |2 NLM | |
| 700 | 1 | |a Berardesca, Enzo |e verfasserin |4 aut | |
| 700 | 1 | |a Blume-Peytavi, Ulrike |e verfasserin |4 aut | |
| 700 | 1 | |a Elsner, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Scafa, Davide |e verfasserin |4 aut | |
| 700 | 1 | |a Schmeel, Leonard Christopher |e verfasserin |4 aut | |
| 700 | 1 | |a Proksch, Ehrhardt |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of dermatological treatment |d 1992 |g 35(2024), 1 vom: 03. Apr., Seite 2326171 |w (DE-627)NLM088851680 |x 1471-1753 |7 nnns |
| 773 | 1 | 8 | |g volume:35 |g year:2024 |g number:1 |g day:03 |g month:04 |g pages:2326171 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/09546634.2024.2326171 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 35 |j 2024 |e 1 |b 03 |c 04 |h 2326171 | ||